Need professional-grade analysis? Visit stockanalysis.com
$2.60B
122.09
4,290
0.03%
Price Chart
Risk-Adjusted Performance
Danel (Adir Yeoshua) Ltd (DANE) Price Performance
Danel (Adir Yeoshua) Ltd (DANE) trades on TA in ILS. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at ILS44950.00, up 0.45% from the previous close.
Over the past year, DANE has traded between a low of ILS36053.58 and a high of ILS54160.00. The stock has gained 21.2% over this period. It is currently 17.0% below its 52-week high.
Danel (Adir Yeoshua) Ltd has a market capitalization of $2.60B, with a price-to-earnings ratio of 122.09 and a dividend yield of 0.03%.
About Danel (Adir Yeoshua) Ltd
Danel (Adir Yeoshua) Ltd provides human resources services in Israel. The company provides recruitment, placement, and employment services in the areas of finance, insurance, senior management, high-tech, biotech, cleantech, outsourcing project management, technological employee employment, and occupational diagnosis service; and nursing and medical services to disabled seniors, Ministry of Defense beneficiaries, and others. It also manages and operates dormitories and hostels, schools, rehabilitation/therapeutic day centers, and employment sector for people with intellectual developmental and learning disabilities, and autism. In addition, the company provides medical services, including surgical activities in ophthalmology field. It serves government ministries, public bodies, the defense industries, and private companies. Danel (Adir Yeoshua) Ltd was incorporated in 1974 and is based in Ramat Gan, Israel.
Company Info
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- TA
- Currency
- ILS
- Country
- Israel
Financial Metrics
- Revenue (TTM)
- $2.87B
- EBITDA
- $218.53M
- Profit Margin
- 0.75%
- EPS (TTM)
- 3.59
- Book Value
- 89.79
Technical Indicators
- 52 Week High
- ₪54,980.00
- 52 Week Low
- ₪35,543.67
- 50 Day MA
- ₪46,812.60
- 200 Day MA
- ₪47,320.90
- Beta
- -0.04
Valuation
- Trailing P/E
- 122.09
- Forward P/E
- N/A
- Price/Sales
- 0.90
- Price/Book
- 5.16
- Enterprise Value
- $2.82B